The serum in chronic myelogenous leukemia (CML) has an increased concentration of vitamin B12 (1, 2) and an increased capacity to bind added vitamin B,2 either in vivo (3) (4) (5) or in vitro (2, 6, 7) . The vitamin B12 of normal and CML serum moves with the a-globulins when serum is electrophoresed at pH 8.6 (1, 8, 9) . The seromucoid, the fraction of serum containing glycoproteins which comprises about 1.5 per cent of the serum proteins (10) , moves with the a-globulins when electrophoresed at pH 8.6 (11) . Furthermore, it has been found that the seromucoid fraction isolated from CML serum is capable of binding amounts of added cobaltOO-labeled vitamin B12 (B,2*) sufficient to account for the increased binding capacity of the whole serum (12) . The possibility that the binding protein of both normal and CML serum for native vitamin B,2 (B,2BP) is in the seromucoid fraction was investigated.
METHODS
Venous blood was collected in the fasting state from normal subjects and from patients with CML in hematological and clinical relapse. About one to two hours after clotting, the serum was separated and either used immediately or stored at -20'C. The seromucoid fraction of serum was prepared by the method of Winzler, Devor, Mehl and Smyth (10) as follows: one volume of serum was added to one volume of 0.4 M sulfosalicylic acid, thoroughly mixed for five minutes, and then centrifuged. The supernatant containing the seromucoid was separated and neutralized with 1 N NaOH. The neutralized seromucoid and the original serum from which it had been prepared were dialyzed against large volumes of 0.15 M NaCl for 72 hours at 4 to 6'C. and its vitamin B,2, concentration then determined by Euglena gracilis assay (13) . When used for electrophoresis, the seromucoid was dialyzed for 72 hours against large volumes of distilled water, lyophilized, and the dried * Presented at the subspecialty meetings, Annual Meeting of The American Society for Clinical Investigation, May 3, 1959 Zone electrophoretic separation of serum or lyophilized seromucoid was performed using starch blocks as the supporting medium. The general technique described by Kunkel (15) and sialic acid concentration of 1.0 cm. segments of the block determined.
After electrophoresis, the starch segments containing nondialyzable B.* were placed in test tubes and the radioactivity determined in a plastic scintillation well counter (20) having a background of 385 to 400 counts per minute. Samples with higher counting rates, such as a) the origin and first four cathodal segments of normal sera, b) anodal segments of the seromucoid and c) the anodal and cathodal segments of CML sera, were counted long enough to give a 10 to 15 per cent counting error. The anodal segments of the normal sera contained small amounts of radioactivity (as little as five to 10 counts per minute over background) and were counted for three to four 10 minute periods with 10 minute counts of background alternating between each sample count. The radioactivity of the Bu* solution added to serum was counted in the same well counter using similar geometry, and the concentration of vitamin B12 in this solution was also determined. From the a) specific activity of the added B=* and b) radioactivity found in each starch segment, the amount of B,2* (ygg.) per segment was estimated. The total vitamin Bn2 bound by the proteins in any starch segment was calculated by summing of the native vitamin Bu2 (determined by E. gracilis assay) and of the nondialyzable B12*.
RESULTS
Vitamin B12 concentration of the seromucoid The seromucoid contained an average of 77 per cent, range 62 to 98 per cent, of the vitamin B12 of whole normal serum (Table I) Figure 1 . The protein and sialic acid were concentrated in segments anodal to the origin with peak levels found in the A-3 and A-4 segments. A similar distribution of protein and sialic acid was found when a crystalline preparation of the acidic a,-glycoprotein was electro- VITAMIN phoresed at pH 4.5. The vitamin B,, was also found anodally with peak concentrations at A-3 to A-5 segments. The B,2* bound to the normal seromucoid had a distribution similar to the native vitamin, with peak concentrations at A-2 to A-4 segments ( Figure 2 ). The distribution of protein, sialic acid and vitamin B12 in the CML seromucoid was similar to that of the normal, with peak concentrations found at A-3 to A-4 segments (Figure 3) . Furthermore, the distribution of added B12* bound by CML seromucoid was similar to that of the native vitamin, with peak concentrations located at A-2 to A-4 segments (Figure 4 Figure 6 and Figure 6 . The solid dots *-* refer to protein concentration. A large fraction of the native vitamin B12 of normal serum was found in the seromucoid. Cohn Fraction VI, thought to be similar to the seromucoid in composition (19) , contained little of the vitamin. In Method VI of Cohn and associates, the major protein fractions of plasma are isolated by a series of precipitations which depend on changes in pH, ionic strength and ethanol concentration ( 14) . Some coprecipitation of the seromucoid routinely occurs when it is prepared from serum by precipitation of the serum proteins with sulfosalicylic or perchloric acid (10) , and similarly it may be presumed that coprecipitation of the B12BP with each Cohn plasma fraction may account for the absence of selective concentration of the vitamin in Fraction VI.
Since the great bulk of serum proteins have isoelectric points of 4.5 or higher, they either remained at the origin or migrated cathodally at this pH. However, due to the more acidic isoelectric point of the B12BP, it migrated anodally with the other proteins of the seromucoid. The native vitamin B12 in serum or seromucoid preparations was usually distributed over a relatively wide anodal area of the starch block, with peak concentrations found in a 2 to 3 cm. width. Trailing of the protein and/or diffusion of the B12BP during the electrophoretic run may account for the wide distribution of the vitamin and does not necessarily indicate the presence of more than one binding protein. The anodal distribution of vitamin B12 was simliar to, but not identical with, that of the main protein and sialic acid peaks of the seromucoid or its chief constituent, the acidic a1-glycoprotein (19, 21) . Despite their somewhat similar mobility, the B12BP is probably not the acidic a1-glycoprotein, since 1) the B12BP was not selectively precipitated with Cohn Fraction VI, whereas the acidic a1-glycoprotein has been found only in this fraction (19) ; and 2) Fahey, McCoy and Goulian fractionated serum on a diethylaminoethyl cellulose ion-exchange column and found that the B12BP was eluted off before the acidic a1-glycoprotein (22) . A small amount of the native vitamin B12 of normal serum (10 per cent) was found scattered among cathodally moving proteins. It is impossible to know whether this represents technical error in the measuring of small amounts of the vitamin or another B12BP.
The B,2BP of CML serum had properties similar to the normal B12BP since 1) it was found in the seromucoid, and 2) had anodal mobility when electrophoresed on starch gel at pH 4.5. Mendelsohn, Watkin, Horbett and Fahey found that both the normal and CML B12BP behaved similarly when serum was chromatographed on a diethylaminoethyl cellulose ion-exchange column (23) . These chemical similarities between the normal and the CML B12BP strongly suggest that the increased concentrations of vitamin B12 uniformly found in CML serum in relapse is due to an increase in concentration of the normal B12BP rather than to an abnormal protein. Despite the tremendous increases in concentration of the B12BP in CML sera (amounting to as much as 100-fold in one patient we have studied), only slight increases in the concentration of the total seromucoid fraction have been reported in this disease (24) . However, the concentration of B12BP in normal serum is probably minute as compared to that of the total seromucoid. Thus, the B12BP of a typical normal serum, when completely saturated, can bind approximately 0.65 mjug. per ml. If the molecular weight of the B12BP is similar to that of the orosomucoid, i.e., 44,000 (25) 1 . A method for the separation of the vitamin B12-binding protein (B12BP) of normal and chronic myelogenous leukemia serum by electrophoresis on starch gel at pH 4.5 has been described, 2 . The B12BP of normal serum has been identified as a constituent of the seromucoid fraction of serum. It is a protein with an electrophoretic mobility at pH 4.5 similar to that of the acidic a,-glycoprotein, the most acidic protein found in serum. However, it was not selectively precipitated with Cohn Fraction VI.
3. The B12BP of chronic myelogenous leukemia serum had properties similar to the normal B12BP, suggesting that the great increase in vitamin B12 levels found in chronic myelogenous leukemia sera results from an increased concentration of the normal B12BP rather than from an. abnormal protein.
4. Only a very small fraction of the cobalt60-labeled vitamin B12 bound by normal serum as determined by dialysis was bound to the B12BP. In contrast to the normal, the largest fraction of the cobalt6O-labeled vitamin B12 bound by chronic myelogenous leukemia serum was bound by the B12BP.
